NCT05351762 2022-07-05
Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC
Xijing Hospital
Phase 2 Unknown
Xijing Hospital
Eye & ENT Hospital of Fudan University
Fudan University
Sun Yat-sen University
National Cancer Institute (NCI)